NewsBite

Pro Medicus Limited

ASX Announcements

Change of Director's Interest Notice - Alice Williams

Change of Director’s Interest Notice

  • Oct 30, 2024
  • 3 pages

PME Annual General Meeting virtual online guide

Notice of Meeting - Other

  • Oct 24, 2024
  • 6 pages

Notice of Annual General Meeting and Proxy Form

Notice of Annual General Meeting, Proxy Form, Web Casts, Letter to Shareholders

  • Oct 24, 2024
  • 17 pages

Market Sensitive

PME signs $32M, 5-year contract extension in Australia

Progress Report

  • Oct 16, 2024
  • 2 pages

AGM Date

Notice of Meeting - Other

  • Oct 8, 2024
  • 1 page

View all PME announcements

This Month

Fromt left: Chemist Warehouse co-founder Mario Verrocchi, Reece Group’s Peter Wilson, Canva’s Melanie Perkins, and Pro Medicus co-founder Sam Hupert.

Five founders keeping the faith with investors

Corporate Australia has recently experienced a founder “killing season”, but these founder-led companies are still keeping shareholders happy.

September

Do you know this week’s news? Answer these 10 questions

Have you been paying attention this week? Test your knowledge across politics, business and world news.

  • Daniel Arbon
Pro Medicus chief Sam Hupert says simplicity is the key to the compay’s success.

Pro Medicus’ billionaire boss says simplicity secret of success

Pro Medicus’ stranglehold on cloud-imaging healthcare tech means its growth trajectory has a long way to go.

  • Michael Smith

Why these tech companies’ M&A plans have stalled

It’s a tough environment for tech companies wanting to buy assets and grow. The disconnect between public and private markets is making it worse.

  • Tess Bennett

August

Richard White founded WiseTech in October 1994 and owns about 35 per cent of the logistics business.

Why tech bolters are lighting up reporting season

WiseTech, Pro Medicus, Life 360 and REA Group have turned heads this season as tech proves the sweet spot for growth investors again.

  • Tom Richardson
Advertisement
Pro Medicus chief executive Sam Hupert.

Pro Medicus share surge defies growth warning

Shares in market darling Pro Medicus jumped on the company’s latest bumper profit, but its CEO says that level of growth will be difficult to maintain.

  • Updated
  • Michael Smith
Ryan Stokes has the Seven Group sailing ahead.

Winners from profit season’s big Wednesday

All eyes were on CBA’s monster numbers, but Seven Group Holdings and AGL also delivered nice profit growth – and Pro Medicus impressed yet again.

  • James Thomson and Anthony Macdonald

July

Richard White’s WiseTech has always been profitable.

Nation’s richest boss ‘can’t find anything to invest in’ but WiseTech

This year’s list is stacked with tech founders such as Richard White – and shows how divorces can force bosses down the ranks.

  • Patrick Durkin and Sally Patten
Rich bosses: Richard White, Andrew Forrest, and Peter Wilson.

The 10 wealthiest executives in the ASX 300 revealed

The Australian Financial Review’s Rich Bosses list for 2024 is dominated by tech and mining executives and also welcomes a new face.

  • Euan Black
Sam Hupert of Pro Medicus says a lack of debt has been an important part of the company’s success.

The secrets to becoming a rich boss

There are good reasons why tech companies dominate this year’s Rich Bosses list.

  • Patrick Durkin and Sally Patten

June

Pro Medicus overtook Life360 during trading on Friday to become the best performing ASX stock in the last financial year.

The five best-performing stocks this financial year

A healthcare software developer has narrowly beat a family monitoring app to be the top-performing stock in 12 months.

  • Joshua Peach
The key to dividend investing is in understanding the cyclical and structural risks to a business’s cash flow.

The top 20 stocks by dividend return this year

Insurers, miners and fund managers were the top performers, but experts warn of income traps.

  • Lucy Dean

Aussie tech stocks that could supercharge a portfolio

These seven companies have collectively returned an astonishing 1151 per cent since 2016.

  • James Weir

May

Rich Listers Sam Hupert (pictured) and Anthony Hall’s Pro Medicus has become one of the most highly valued companies on the ASX with a PE multiple of 169.

The ASX business so good ‘you can’t put a sell on it’

Analysts say Pro Medicus is one of the world’s most expensive stocks, but also one of the best.

  • Yolanda Redrup

April

Markets could be heading for a more difficult period of higher rates and lower growth.

12 stock picks for a tough investing environment

Low rates and endless stimulus may have left investors unprepared for the difficult environment that lies ahead. Here are 12 stock picks to consider. 

  • James Thomson
Advertisement

Why Paradice is backing Seven Group’s bid for Boral

Mid-cap investor Jovana Gagic says Kerry Stokes’ conglomerate has a good track record in buying controlling stakes, and reveals why she’s bullish on Orica and Pro Medicus.

  • Joanne Tran

February

Pro Medicus chief executive Sam Hupert has retained a 24 per cent stake in the company.

Pro Medicus share price pause ‘a good entry point’

A $2.8 million share buyback has helped restore $1.2 billion of value to Pro Medicus. Despite its sky-high multiple, bulls think it has further to run.

  • Tess Bennett
The S&P/ASX 200 closed 87.2 points higher, or 1.2 per cent, to 7297.70, the largest single-day gain since mid-July.

Why analysts love these eight medtech stocks

The sector that straddles healthcare and tech has professionals searching for companies that could be tomorrow’s big winners after Pro Medicus.

  • Tom Richardson
Apple’s Vision Pro has an outward-facing screen that shows a video of your eyes.

The Aussies hoping to make a fortune from Apple’s Vision Pro

The $11 billion ASX software giant Pro Medicus and a Melbourne start-up are among the businesses hoping to cash in on Apple’s new $5000 headset.

  • Tess Bennett

January

Gold giant Newmont’s addition to ASX is expected to trigger major changes to the indices.

Newmont to slide down ASX 200 as investors ditch secondary listings

The gold giant’s addition to the Australian Stock Exchange is expected to see a major reshuffle of the indices and $746 million worth of trading at the quarterly rebalance.

  • Alex Gluyas

Original URL: https://www.afr.com/company/pme-18c